Eric Devroe - Net Worth and Insider Trading
Eric Devroe Net Worth
The estimated net worth of Eric Devroe is at least $126,517 dollars as of 2026-06-27. Eric Devroe is the COO of Acrivon Therapeutics Inc and owns about 75,308 shares of Acrivon Therapeutics Inc (ACRV) stock worth over $126,517. Details can be seen in Eric Devroe's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Eric Devroe has not made any transactions after 2026-01-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Eric Devroe
Eric Devroe Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Eric Devroe owns 1 companies in total, including Acrivon Therapeutics Inc (ACRV) .
Click here to see the complete history of Eric Devroe’s form 4 insider trades.
Insider Ownership Summary of Eric Devroe
| Ticker | Company | Transaction Date | Type of Owner |
|---|---|---|---|
| ACRV | Acrivon Therapeutics Inc | 2026-01-13 | Chief Operating Officer |
Eric Devroe Latest Holdings Summary
Eric Devroe currently owns a total of 1 stock. Eric Devroe owns 75,308 shares of Acrivon Therapeutics Inc (ACRV) as of January 13, 2026, with a value of $126,517.
Latest Holdings of Eric Devroe
| Ticker | Company | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ACRV | Acrivon Therapeutics Inc | 2026-01-13 | 75,308 | 1.68 | 126,517 |
Holding Weightings of Eric Devroe
Eric Devroe Form 4 Trading Tracker
According to the SEC Form 4 filings, Eric Devroe has made a total of 1 transactions in Acrivon Therapeutics Inc (ACRV) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Acrivon Therapeutics Inc is the acquisition of 10,000 shares on January 13, 2026, which cost Eric Devroe around $17,200.
Insider Trading History of Eric Devroe
* The information on this page (including Insider Trading Shares, Share Changes, Cost, etc.) is sourced exclusively from Form 4 filings and does not incorporate any data from 13F or 13D/G filings. As a result, it may differ from the values shown on the Guru page.
- 1
Eric Devroe Trading Performance
GuruFocus tracks the stock performance after each of Eric Devroe's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Eric Devroe is -5.29%. GuruFocus also compares Eric Devroe's trading performance to market benchmark return within the same time period. The performance of stocks bought by Eric Devroe within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Eric Devroe's insider trading performs compared to the benchmark.
Performance of Eric Devroe
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -4.12 |  | | | | |
| Relative Return to S&P 500(%) | -2.29 | | | | | |
Eric Devroe Ownership Network
Ownership Network List of Eric Devroe
Ownership Network Relation of Eric Devroe
Eric Devroe Owned Company Details
What does Acrivon Therapeutics Inc do?
Who are the key executives at Acrivon Therapeutics Inc?
Eric Devroe is the Chief Operating Officer of Acrivon Therapeutics Inc. Other key executives at Acrivon Therapeutics Inc include Chief Financial Officer Adam D. Levy , director & President and CEO Peter Blume-jensen , and 10 percent owner Perceptive Life Sciences Master Fund Ltd .
Acrivon Therapeutics Inc (ACRV) Insider Trades Summary
Over the past 18 months, Eric Devroe made 1 insider transaction in Acrivon Therapeutics Inc (ACRV) with a net purchase of 10,000. Other recent insider transactions involving Acrivon Therapeutics Inc (ACRV) include a net sale of 2,256,719 shares made by Perceptive Life Sciences Master Fund Ltd , a net purchase of 49,000 shares made by Peter Blume-jensen , and a net purchase of 8,832 shares made by Adam D. Levy .
In summary, during the past 3 months, insiders sold 0 shares of Acrivon Therapeutics Inc (ACRV) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 2,256,719 shares of Acrivon Therapeutics Inc (ACRV) were sold and 67,832 shares were bought by its insiders, resulting in a net sale of 2,188,887 shares.
Acrivon Therapeutics Inc (ACRV)'s detailed insider trading history can be found in Insider Trading Tracker table.
Acrivon Therapeutics Inc Insider Transactions
Eric Devroe Mailing Address
Above is the net worth, insider trading, and ownership report for Eric Devroe. Based on the public information released on the U.S. Securities and Exchange Commission (SEC) website, Eric Devroe's mailing address is: Watertown Ma 02472.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
